Formulating an effective and efficient written asthma action plan

Mayo Clinic Proceedings

Volumn 83, Issue 11, 2008, Pages 1263-1270

  Rank, Matthew A ^a   Volcheck, Gerald W ^a   Li, James T C ^a   Patel, Ashokakumar M ^a   Lim, Kaiser G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; FORMOTEROL; LEVALBUTEROL; PIRBUTEROL; PREDNISONE; SALBUTAMOL; SALMETEROL; TRIAMCINOLONE;

ASTHMA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; HEALTH SURVEY; HUMAN; METERED DOSE INHALER; NEBULIZATION; PATIENT EDUCATION; PATIENT MONITORING; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SELF CONCEPT; SOCIOECONOMICS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; WRITTEN ASTHMA ACTION PLAN;

EID: 55549146144     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.11.1263     Document Type: Review

References (57)

1. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3 Web site. Guidelines for the diagnosis and management of asthma (EPR-3). www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed September 28, 2008.
2. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007 Jun;119(6):1454-1461. Epub 2007 May 3. doi:10.1016/j.jaci.2007.03.022.
3. Beauchesne, MF, Levert V, El Tawil M, Labrecque M, Blais L. Action plans in asthma. Can Respir J. 2006;13(6):306-310.
4. Douglass J, Aroni R, Goeman D, et al. A qualitative study of action plans for asthma. BMJ. 2002;324(7344):1003-1005. doi:10.1136/bmj.324.7344. 1003.
5. Butz AM, Huss K, Mudd K, Donithan M, Rand C, Bollinger ME. Asthma management practices at home in young inner-city children. J Asthma. 2004;41(4):433-444. doi:10.1081/JAS-120033985.
6. Fernandes AK, Mallmann F, Steinhorst AM, et al. Characteristics of acute asthma patients attended frequently compared with those attended only occasionally in an emergency department. J Asthma. 2003;40(6):683-690. doi:10.1081/JAS-120023487.
7. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-478. doi:10.1111/j.1398-9995.2004.00526.x.
8. Markson LE, Vollmer WM, Fitterman L, et al. Insight into patient dissatisfaction with asthma treatment. Arch Intern Med. 2001;161(3):379-384. doi:10.1001/archinte.161.3.379.
9. Hemp P. Presenteeism: at work - but out of it. Harv Bus Rev. 2004;82(10):49-58, 155.
10. Williams SG, Schmidt DK, Redd SC, Storms W. Key clinical activities for quality asthma care: recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep. 2003;52(RR-6):1-8.
11. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;1:CD001117.
12. Guevara JP, Wolf FM, Grum CM, Clark NM. Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis. BMJ. 2003;326(7402):1308-1309. doi:10.1136/bmj.326.7402.1308.
13. Coffman JM, Cabana MD, Halpin HA, Yelin EH. Effects of asthma education on children's use of acute care services: a meta-analysis. Pediatrics. 2008;121(3):575-586. doi:10.1542/peds.2007-0113.
14. Toelle BG, Ram FS. Written individualised management plans for asthma in children and adults. Cochrane Database Syst Rev. 2004;2:CD002171.
15. Scherer YK, Bruce S. Knowledge, attitudes, and self-efficacy and compliance with medical regimen, number of emergency department visits, and hospitalizations in adults with asthma. Heart Lung. 2001;30(4):250-257. doi:10.1067/mhl.2001.116013.
16. Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364(9444):1523-1537. doi:10.1016/S0140-6736(04) 17277-2.
17. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ. 1996;312(7033):748-752.
18. Fox P, Porter PG, Lob SH, Boer JH, Rocha DA, Adelson JW. Improving asthma-related health outcomes among low-income, multiethnic, school-aged children: results of a demonstration project that combined continuous quality improvement and community health worker strategies. Pediatrics. 2007;120(4):e902-e911. doi:10.1542/peds.2006-1805.
19. Dinakar C, Van Osdol TJ, Wible K. How frequent are asthma exacerbations in a pediatric primary care setting and do written asthma action plans help in their management? J Asthma. 2004;41(8):807-812. doi:10.1081/JAS- 200038418.
20. Mangold RA, Salzman GA. Electronic asthma action plan database: asthma action plan development using Microsoft Access. J Asthma. 2005;42(3):191-196. doi:10.1081/JAS-200054631.
21. D'Souza W, Crane J, Burgess C, et al. Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J. 1994;7(7):1260-1265.
22. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med. 2003;168(7):740-759. doi:10.1164/rccm.200208-902SO.
23. Roberts NJ. Development of a paper and electronic pictorial asthma self-management plan [abstract]. Am J Respir Crit Care Med. 2007;A589.
24. Tattersfield AE, Postma DS, Barnes PJ, et al; FACET International Study Group. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med. 1999;160(2):594-599.
25. Banzett RB, Dempsey JA, O'Donnell DE, Wamboldt MZ. Symptom perception and respiratory sensation in asthma. Am J Respir Crit Care Med. 2000;162(3, pt 1):1178-1182.
26. Wallenstein GV, Carranza-Rosenzweig J, Kosinski M, Blaisdell-Gross B, Gajria K, Jhingran P. A psychometric comparison of three patient-based measures of asthma control. Curr Med Res Opin. 2007;23(2):369-377. doi:10.1185/030079906X167426.
27. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65. doi:10.1016/j.jaci.2003.09.008.
28. Clark NM, Evans D, Mellins RB. Patient use of peak flow monitoring. Am Rev Respir Dis. 1992;145(3):722-725.
29. Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993;307(6901):422-424.
30. Chetta A, Gerra G, Foresi A, et al. Personality profiles and breathlessness perception in outpatients with different gradings of asthma. Am J Respir Crit Care Med. 1998;157(1):116-122.
31. Malo JL, L'Archevêque J, Trudeau C, d'Aquino C, Cartier A. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma? J Allergy Clin Immunol. 1993;91(3):702-709. doi:10.1016/0091-6749(93)90189-M.
32. Clough JB, Sly PD. Association between lower respiratory tract symptoms and falls in peak expiratory flow in children. Eur Respir J. 1995;8(5):718-722.
33. Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med. 1996;154(4, pt 1):889-893.
34. Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med. 1995;151(2, pt 1):353-359.
35. Boushey HA, Sorkness CA, King TS, et al; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352(15):1519-1528. doi:10.1056/NEJMoa042552.
36. Reddel HK, Barnes DJ; Exacerbation Advisory Panel. Pharmacological strategies for self-management of asthma exacerbations. Eur Respir J. 2006;28(1):182-199. doi:10.1183/09031936.06.00105305.
37. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363(9405):271-275. doi:10.1016/S0140-6736(03)15384-6.
38. FitzGerald JM, Shragge D, Haddon J, et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J. 2000;7(1):61-67.
39. Rice-McDonald G, Bowler S, Staines G, Mitchell C. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults. Intern Med J. 2005;35(12):693-698. doi:10.1111/j.1445- 5994.2005.00972.x.
40. Levy ML, Stevenson C, Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax. 1996;51(11):1087-1092.
41. Foresi A, Morelli MC, Catena E; Italian Study Group. Low-dose budesonide with the addition of an increased dose during exacerbation is effective in long-term asthma control. Chest. 2000;117(2):440-446. doi:10.1378/chest.117.2.440.
42. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med. 1998;157(3, pt 1):698-703.
43. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med. 2000;343(10):689-694. doi:10.1056/NEJM200009073431003.
44. Pauwels RA, Löfdahl C-G, Postma DS, et al; Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma [published correction appears in N Engl J Med. 1998;338(2):139]. N Engl J Med. 1997;337(20):1405-1411. doi:10.1056/NEJM199711133372001.
45. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001.164(8, pt 1):1392-1397.
46. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol [published correction appears in Chest. 2006;129(5):1393]. Chest. 2006;129(1):15-26. doi:10.1378/chest.129.1.15.
47. Pauwels RA, Sears MR, Campbell M, et al; RELIEF Study Investigators. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J. 2003;22(5):787-794. doi:10.1183/09031936.03. 00055803.
48. Papi A, Canonica GW, Maestrelli P, et al; BEST Study Group. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040-2052. doi:10.1056/NEJMoa063861.
49. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005 Jan 15;171(2):129-136. Epub 2004 Oct 22. doi:10.1164/rccm.200407-884OC.
50. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2007;3:CD000195.
51. Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev. 2001;1:CD001740.
52. Hasegawa T, Ishihara K, Takakura S, et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation: a randomized study. Intern Med. 2000;39(10):794-797. doi:10.2169/internalmedicine.39.794
53. O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993;341(8841):324-327. doi:10.1016/0140-6736(93)90134-3.
54. Webb J, Clark TJ. Recovery of plasma corticotrophin and cortisol levels after a three-week course of prednisolone. Thorax. 1981;36(1):22-24.
55. Hatton MQ, Vathenen AS, Allen MJ, Davies S, Cooke NJ. A comparison of 'abruptly stopping' with 'tailing off' oral corticosteroids in acute asthma. Respir Med. 1995;89(2):101-104. doi:10.1016/0954-6111(95)90191-4.
56. Cydulka RK, Emerman CL. A pilot study of steroid therapy after emergency department treatment of acute asthma: is a taper needed? J Emerg Med. 1998;16(1):15-19. doi:10.1016/S0736-4679(97)00227-8.
57. Karan RS, Pandhi P, Behera D, Saily R, Bhargava VK. A comparison of non-tapering vs. tapering prednisolone in acute exacerbation of asthma involving use of the low-dose ACTH test. Int J Clin Pharmacol Ther. 2002;40(6):256-262.